GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (TSX:OGI) » Definitions » Gross-Profit-to-Asset %

Organigram Global (TSX:OGI) Gross-Profit-to-Asset % : 14.49% (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Organigram Global Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Organigram Global's annualized Gross Profit for the quarter that ended in Mar. 2025 was C$73.7 Mil. Organigram Global's average Total Assets over the quarter that ended in Mar. 2025 was C$508.6 Mil. Therefore, Organigram Global's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 14.49%.


Organigram Global Gross-Profit-to-Asset % Historical Data

The historical data trend for Organigram Global's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global Gross-Profit-to-Asset % Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.26 -13.08 -5.74 5.58 9.65

Organigram Global Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.18 16.32 18.06 12.46 14.49

Competitive Comparison of Organigram Global's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Organigram Global's Gross-Profit-to-Asset % falls into.


;
;

Organigram Global Gross-Profit-to-Asset % Calculation

Organigram Global's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Sep. 2024 )/( (Total Assets (A: Aug. 2022 )+Total Assets (A: Sep. 2024 ))/ count )
=47.524/( (577.107+407.86)/ 2 )
=47.524/492.4835
=9.65 %

Organigram Global's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=73.672/( (479.207+537.903)/ 2 )
=73.672/508.555
=14.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Organigram Global Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Organigram Global's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Executives
Beena Goldenberg Senior Officer
Dexter John Director
Sherry Porter Director
Stephen A. Smith Director
Gregory Guyatt Senior Officer
Paolo De Luca Senior Officer
Katrina May Mcfadden Senior Officer
Donald Geoffrey Machum Director
Derrick West Senior Officer
Michel Bourque Director
Kenneth Arnold Mitton Director
Denis Joseph Robert Arsenault 10% Security Holder, Director, Senior Officer